应用全外显子测序和显微切割技术识别1 例肺癌患者高频突变基因的异质性探索

目的:通过对一例肺鳞癌患者全外显子测序来识别这例肺癌的可能致病基因,并通过显微切割初步探索这例肺癌肿瘤细胞的起源与演化。方法:利用全外显子测序技术对肺癌肿瘤组织和相应癌旁组织测序;用COSMIC肿瘤数据库比较分析统计出肺癌可能致病基因;用激光显微切割技术提取五个不同部位肿瘤细胞;巢式PCR扩增,一代测序验证基因分型。结果:发现了这例肺癌病人的7个高频突变基因:LPHN2、TP53、MYH2、TGM2、C10orf137、MS4A3和EP300;这些基因在10×镜下和20×镜下经显微切割的肺癌组织的5个不同部位上的基因分型不同。结论:我们通过全外显子测序发现了这例肺癌的7个可能致病基因,并初步探索了这例肺癌肿瘤细胞是多克隆起源的。     

冬虫夏草寄主蒲氏钩蝠蛾雄成虫触角感受器的观察

蒲氏钩蝠蛾Thitarodes pui(Zhang et al.)是冬虫夏草寄主昆虫之一,其雄成虫触角感受器在求偶交配过程中起主要作用。本研究应用电子扫描显微镜对蒲氏钩蝠蛾雄成虫触角上的化学感受器进行观察。结果发现,雄成虫触角上有7种感受器,即毛形感受器、刺形感受器、锥形感受器、腔锥形感受器、钟形感受器、Bhm氏鬃毛和鳞形感受器,其中以毛形感受器和鳞形感受器数目最多,腔锥感受器又分为长栓形和短栓形两种。综合本研究结果与已知蝠蛾的触角感受器,发现蝠蛾触角感受器在表面结构、感受器类型等方面与其它鳞翅目昆虫存在差异。     

红缘天牛成虫对杏树挥发物的生理和行为反应

为了研究红缘天牛成虫对寄主植物杏树衰弱树及木段挥发物的生理及行为反应,本文用6种挥发物,分别以不同浓度的单一组份对红缘天牛进行了电生理和行为测试;又在这6种单组份化合物对天牛行为选择表现为引诱活性的浓度范围内选择EAG值最高的浓度,以4-6种化合物等体积制成7种组合配方进行EAG和行为测试。结果表明:单一组份R-柠檬烯、反-2-己烯醛、丁酸丁酯、S-柠檬烯、异戊醇和3-蒈烯等6种单一化合物在预设的8个浓度梯度范围内,都能引起红缘天牛产生一定的生理反应,但行为选择实验的结果没有统计学意义。7种组合配方中,R4对红缘天牛成虫引诱活性最强(P0.01),引诱率达到76.67%,R1次之(P0.05),R4与R1的区别在于增加了丁酸丁酯;即丁酸丁酯在R4配方中具有明显的增效作用。     

拟小食螨瓢虫成虫对朱砂叶螨的觅食行为

为明确拟小食螨瓢虫的觅食特性,揭示其觅食行为机制,本研究针对拟小食螨瓢虫成虫对朱砂叶螨不同虫态的取食选择、日取食节律以及觅食行为活动特点等进行了观察和阐述。结果表明,拟小食螨瓢虫成虫对朱砂叶螨卵、幼螨、若螨和成螨的取食嗜好性有显著差异,取食量分别为23.2、15.8、10.5和8.0头;瓢虫对成螨的平均日取食量为14.7头,其中在白天其觅食行为较频繁,9∶00-12∶00为捕食高峰期,此时段的平均取食量为4.0头成螨,夜间基本不取食;其觅食行为过程主要分为7个部分:搜索、捕捉、嚼食、梳理、展翅、排泄和静止。     

绿僵菌及其与dsRNA混合使用对褐飞虱的防治效果

褐飞虱Nilaparvata lugens Stl是我国重要的迁飞性水稻害虫,本文研究了金龟子绿僵菌Metarhizium anisopliae及其与dsRNA混合使用对褐飞虱的防治效果。绿僵菌悬浮液1.6×108孢子/m L至8×106孢子/m L对褐飞虱2龄、4龄和成虫进行喷药,发现1.6×107孢子/m L对各个虫态虫龄均有良好致死效果,并且成虫和4龄若虫均好于2龄若虫。在交配行为上来看,绿僵菌处理过的褐飞虱成虫活跃度非常低,从配对开始一直到交配结束的各个阶段都受到明显影响,处理组3 h的交配率只有3.70%,而对照组的交配率为24.44%。还把褐飞虱几丁质合成酶基因A的dsRNA与绿僵菌混合使用防治褐飞虱2龄和4龄若虫,结果表明0.5μg/μL ds CHSA与绿僵菌混合使用的防治效果最好,2龄若虫的死亡率为89.63%,4龄若虫的死亡率达到93.94%。而0.2μg/μL ds CHSA与绿僵菌的混合,对2龄和4龄若虫的致死率为65.56%-76.52%。研究结果为褐飞虱的生物防治提供了新的思路。     

昆虫几丁质酶基因家族功能研究进展

昆虫几丁质酶的研究历史很长,研究内容也非常广泛;但仅局限于传统的方法研究某个昆虫单个基因的功能及应用。近年来,随着生物信息学和RNAi技术在生命科学研究工作中的广泛应用,在昆虫几丁质酶的研究方面也取得了较大进展。本文主要以生物信息学在几丁质酶家族基因鉴定和分类研究过程中的应用,以及利用RNAi技术分析几丁质酶不同家族成员在赤拟谷盗和褐飞虱两种昆虫生长发育中的功能比较分析,对全面认识昆虫几丁质酶基因家族功能和作用机理,并利用几丁质酶基因防治害虫奠定良好的基础。     

Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters

The aim of this article was to construct a T–ϕ phase diagram for a model drug (FD) and amorphous polymer (Eudragit® EPO) and to use this information to understand the impact of how temperature–composition coordinates influenced the final properties of the extrudate. Defining process boundaries and understanding drug solubility in polymeric carriers is of utmost importance and will help in the successful manufacture of new delivery platforms for BCS class II drugs. Physically mixed felodipine (FD)–Eudragit^® EPO (EPO) binary mixtures with pre-determined weight fractions were analysed using DSC to measure the endset of melting and glass transition temperature. Extrudates of 10 wt% FD–EPO were processed using temperatures (110°C, 126°C, 140°C and 150°C) selected from the temperature–composition (T–ϕ) phase diagrams and processing screw speed of 20, 100 and 200rpm. Extrudates were characterised using powder X-ray diffraction (PXRD), optical, polarised light and Raman microscopy. To ensure formation of a binary amorphous drug dispersion (ADD) at a specific composition, HME processing temperatures should at least be equal to, or exceed, the corresponding temperature value on the liquid–solid curve in a F–H T–ϕ phase diagram. If extruded between the spinodal and liquid–solid curve, the lack of thermodynamic forces to attain complete drug amorphisation may be compensated for through the use of an increased screw speed. Constructing F–H T–ϕ phase diagrams are valuable not only in the understanding drug–polymer miscibility behaviour but also in rationalising the selection of important processing parameters for HME to ensure miscibility of drug and polymer.KEY WORDS: DSC, Flory–Huggins theory, hot-melt extrusion, thermal processing     

High glucose concentration induces endothelial cell proliferation by regulating cyclin‐D2‐related miR‐98

Cyclin D2 is involved in the pathology of vascular complications of type 2 diabetes mellitus (T2DM). This study investigated the role of cyclin‐D2‐regulated miRNAs in endothelial cell proliferation of T2DM. Results showed that higher glucose concentration (4.5 g/l) significantly promoted the proliferation of rat aortic endothelial cells (RAOECs), and significantly increased the expression of cyclin D2 and phosphorylation of retinoblastoma 1 (p‐RB1) in RAOECs compared with those under low glucose concentration. The cyclin D2‐3′ untranslated region is targeted by miR‐98, as demonstrated by miRNA analysis software. Western blot also confirmed that cyclin D2 and p‐RB1 expression was regulated by miR‐98. The results indicated that miR‐98 treatment can induce RAOEC apoptosis. The suppression of RAOEC growth by miR‐98 might be related to regulation of Bcl‐2, Bax and Caspase 9 expression. Furthermore, the expression levels of miR‐98 decreased in 4.5 g/l glucose‐treated cells compared with those treated by low glucose concentration. Similarly, the expression of miR‐98 significantly decreased in aortas of established streptozotocin (STZ)‐induced diabetic rat model compared with that in control rats; but cyclin D2 and p‐RB1 levels remarkably increased in aortas of STZ‐induced diabetic rats compared with those in healthy control rats. In conclusion, this study demonstrated that high glucose concentration induces cyclin D2 up‐regulation and miR‐98 down‐regulation in the RAOECs. By regulating cyclin D2, miR‐98 can inhibit human endothelial cell growth, thereby providing novel therapeutic targets for vascular complication of T2DM.